Clinuvel Pharmaceuticals Limited (CLVLF)
OTCMKTS · Delayed Price · Currency is USD
7.45
0.00 (0.00%)
Sep 4, 2025, 8:00 PM EDT
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $359.83 million as of September 8, 2025. Its market cap has decreased by -23.14% in one year.
Market Cap
359.83M
Enterprise Value
213.12M
Revenue
62.29M
Ranking
n/a
PE Ratio
15.17
Stock Price
$7.45
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 2.79M to 359.83M, an increase of 12,802.22%. That is a compound annual growth rate of 21.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 359.83M | -3.47% |
| Dec 31, 2024 | 372.77M | -31.82% |
| Dec 29, 2023 | 546.72M | -24.87% |
| Dec 30, 2022 | 727.74M | -25.56% |
| Dec 31, 2021 | 977.57M | 14.90% |
| Dec 31, 2020 | 850.82M | -13.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 760.21M |
| Tian'an Technology Group | 673.67M |
| Glass House Brands | 576.95M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 387.41M |
| American Oncology Network | 352.23M |